Paper
0
Outcomes with HMA Plus Venetoclax Vs Intensive Chemotherapy in AML Patients with Chromosome 5 and 7 Abnormalities
Authors
Leora Boussi,Jan Bewersdorf
Yiwen Liu,Rory Shallis,Luis Aguirre,Andrius Žučenka,Sylvain Garciaz,Rebecca Bystrom,Daniel DeAngelo,Richard Stone,Marlise Luskin,Jacqueline Garcia,Eric Winer,Evan Chen,Martha Wadleigh,Kelly Ling,Amer Zeidan,Aaron Goldberg,Eytan Stein,Shai Shimony
+18 authors
,Maximilian StahlJournal
Published
Nov 5, 2024
Show more
Save
Tip0
TipSave